Company · CIK 1869105

# BridgeBio Oncology Therapeutics, Inc.

| CIK | [1869105](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001869105) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BBOT (Nasdaq) |
| First annual or quarterly report | 2024-05-15 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298697 | Shelf Effective | 2026-09-01 | 2026-09-10 | 2 |
| 333-289940 | Registered company Effective | 2025-08-29 | 2026-09-08 | 4 |
| 333-276591 | IPO Final prospectus | 2024-01-18 | 2024-02-13 | 5 |

## Filings

 16

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999526002939/9999999995-26-002939-index.htm) Declared effective | 333-298697 | 9999999995-26-002939 |
| 2026-09-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999526002909/9999999995-26-002909-index.htm) Declared effective | 333-289940 | 9999999995-26-002909 |
| 2026-09-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1869105/000119312526378637/0001193125-26-378637-index.htm) Shelf registered | 333-298697 | 0001193125-26-378637 |
| 2026-05-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999526001459/9999999995-26-001459-index.htm) Declared effective | 333-289940 | 9999999995-26-001459 |
| 2025-09-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999525002915/9999999995-25-002915-index.htm) Declared effective | 333-289940 | 9999999995-25-002915 |
| 2025-08-29 | [S-1](https://www.sec.gov/Archives/edgar/data/1869105/000119312525192760/0001193125-25-192760-index.htm) Registration filed | 333-289940 | 0001193125-25-192760 |
| 2025-08-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999525002673/9999999995-25-002673-index.htm) Declared effective | 333-288222 | 9999999995-25-002673 |
| 2025-07-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999525002217/9999999995-25-002217-index.htm) Declared effective | 333-288222 | 9999999995-25-002217 |
| 2025-07-10 | [424B4](https://www.sec.gov/Archives/edgar/data/1869105/000121390025062864/0001213900-25-062864-index.htm) Final prospectus | 333-288222 | 0001213900-25-062864 |
| 2025-04-15 | [DRS](https://www.sec.gov/Archives/edgar/data/1869105/000121390025031720/0001213900-25-031720-index.htm) Draft made public | 377-07895 | 0001213900-25-031720 |
| 2024-02-13 | [424B4](https://www.sec.gov/Archives/edgar/data/1869105/000121390024012731/0001213900-24-012731-index.htm) Final prospectus | 333-276591 | 0001213900-24-012731 |
| 2024-02-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1869105/999999999524000357/9999999995-24-000357-index.htm) Declared effective | 333-276591 | 9999999995-24-000357 |
| 2024-02-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1869105/000121390024010676/0001213900-24-010676-index.htm) Amendment | 333-276591 | 0001213900-24-010676 |
| 2024-02-02 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1869105/000121390024009481/0001213900-24-009481-index.htm) Amendment | 333-276591 | 0001213900-24-009481 |
| 2024-01-18 | [S-1](https://www.sec.gov/Archives/edgar/data/1869105/000121390024004590/0001213900-24-004590-index.htm) Registration filed | 333-276591 | 0001213900-24-004590 |
| 2023-12-20 | [DRS](https://www.sec.gov/Archives/edgar/data/1869105/000121390023097208/0001213900-23-097208-index.htm) Draft made public | 377-07010 | 0001213900-23-097208 |

[All filings of this company](https://equitycapital.markets/filings?cik=1869105) · [CSV](https://equitycapital.markets/filings.csv?cik=1869105)

---
Source page: https://equitycapital.markets/company/1869105 · Data: U.S. SEC EDGAR · CC BY 4.0